Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Looking4Doubleson Jul 27, 2020 10:51pm
129 Views
Post# 31328439

RE:RE:KALYTERA - STRONG BUY!

RE:RE:KALYTERA - STRONG BUY!
Newinvestor68 wrote: Too bad Kaly doesn't have it in a gas. No one besides a few dreamers and Kaly are taking about the wonder drug that can be injected. Why is that? Because it doesn't work? If it does then why is it not fast tracked? 


Maybe it will be !

“It’s a pretty remarkable drug,” said Dr. Lorenzo Berra, the critical-care specialist at Massachusetts General who is overseeing the new, international trial. “It has a risk profile that is minimal.”

The study administers inhaled nitric oxide to patients with mild to moderate cases of the coronavirus. The gas is delivered through a CPAP breathing machine for 20-30 minutes twice a day.

 
“We have tremendous confidence this therapy will alter the devastating effects of COVID-19 but we must test it. If results show promise, and since this gas is already FDA-approved, widespread use could begin immediately,” said Dr. Keith Scott

Yes, I know the gas is being tested and not the injection in this case, but does anyone not think the injected version wouldn't get fast tracked at this point.  ?  (The virus is world-wide !)  As has been highlighted before, there isn't enough equipment available to provide the gaseous option, nor . . the technicians to do it.
<< Previous
Bullboard Posts
Next >>